TABLE 1.
Half-maximal inhibitory concentrations (IC50 values) of organotin(IV) derivatives.
No | Compounds | IC50 (μM) | References | |||||||
---|---|---|---|---|---|---|---|---|---|---|
HeLa | A549 | HCT-116 | HepG2 | MCF-7 | K562 | HL-60 | Jurkat E6.1 | |||
1 | Et2SnL1 | — | 82.4 | — | — | 79.7 | — | — | — | Devi et al. (2020) |
2 | Bu2SnL1 | — | 77.5 | — | — | 74.2 | — | — | — | Devi et al. (2020) |
3 | Ph2SnL1 | — | 86.4 | — | — | 95.7 | — | — | — | Devi et al. (2020) |
4 | Me2SnL2 | — | 94.1 | — | — | 91.2 | — | — | — | Devi et al. (2020) |
5 | Et2SnL2 | — | 13.4 | — | — | 15.2 | — | — | — | Devi et al. (2020) |
6 | Bu2SnL2 | — | 84.6 | — | — | 83.2 | — | — | — | Devi et al. (2020) |
7 | Ph2SnL2 | — | 73.1 | — | — | 71.2 | — | — | — | Devi et al. (2020) |
8 | Me2SnL3 | — | 85.7 | — | — | 82.5 | — | — | — | Devi et al. (2020) |
9 | Et2SnL3 | — | 29.6 | — | — | 27.8 | — | — | — | Devi et al. (2020) |
10 | Ph2SnL3 | — | 80.5 | — | — | 77.1 | — | — | — | Devi et al. (2020) |
11 | Me2SnL4 | — | 107.9 | — | — | 103.2 | — | — | — | Devi et al. (2020) |
12 | Et2SnL4 | — | 23.8 | — | — | 20.5 | — | — | — | Devi et al. (2020) |
13 | Bu2SnL4 | — | 33.6 | — | — | 31.2 | — | — | — | Devi et al. (2020) |
14 | Ph2SnL4 | — | 106.7 | — | — | 104.2 | — | — | — | Devi et al. (2020) |
15 | n-Bu3Sn(5tpO) | — | — | 0.07 | 0.07 | 0.23 | — | — | — | Attanzio et al. (2020) |
16 | n-Bu3Sn(mtpO) | — | — | 0.034 | 0.053 | 0.118 | — | — | — | Attanzio et al. (2020) |
17 | n-Bu3Sn(HtpO2) | — | — | 0.1 | 0.117 | 0.487 | — | — | — | Attanzio et al. (2020) |
18 | Ph3Sn(HtpO2) | — | — | 0.06 | 0.063 | 0.102 | — | — | — | Attanzio et al. (2020) |
19 | (C6H5)2Sn[S2CN(C3H7O) (CH3)]2 | — | — | — | — | — | 4.0 | — | — | Kamaludin et al. (2019) |
20 | (C6H5)3Sn[S2CN(C3H7O) (CH3)] | — | — | — | — | — | 8.0 | — | — | Kamaludin et al. (2019) |
21 | (C4H9)ClSnL2 | 758 | — | — | — | — | — | — | — | Adeyemi et al. (2019) |
22 | (CH3)2SnL2 | 56 | — | — | — | — | — | — | — | Adeyemi et al. (2019) |
23 | (C4H9)2SnL2 | 288 | — | — | — | — | — | — | — | Adeyemi et al. (2019) |
24 | (C6H5)2SnL2 | 2 | — | — | — | — | — | — | — | Adeyemi et al. (2019) |
25 | Me2SnL1 | 14.4 | 9.9 | — | — | — | — | — | — | Liu et al. (2017) |
26 | Ph2SnL1 | 0.62 | 1.2 | — | — | — | — | — | — | Liu et al. (2017) |
27 | Me2SnL2 | 34.69 | 19.50 | — | — | — | — | — | — | Liu et al. (2017) |
28 | Ph2SnL2 | 1.25 | 3.4 | — | — | — | — | — | — | Liu et al. (2017) |
29 | (C4H9)2SnL | — | — | — | — | — | — | 0.40 | — | Awang et al. (2016) |
30 | (C6H5)2SL | — | — | — | — | — | — | 0.35 | — | Awang et al. (2016) |
31 | n-Bu3SnCl | — | — | — | — | 0.0027 | — | — | — | Fickova et al. (2015) |
32 | Ph3SnCl | — | — | — | — | 0.609 | — | — | — | Fickova et al. (2015) |
33 | {[Ph3SnL]·0.5C6H6}n | 1.76 | — | — | — | — | — | — | — | Liang et al. (2014) |
34 | [Bu2LSnOSnLBu2]2 | 6.6 | — | — | — | — | — | — | — | Liang et al. (2014) |
35 | Ph2Sn(mstsc) | — | — | — | — | — | — | — | 0.3 | Khandani et al. (2013) |
36 | Me2Sn(mstsc) | — | — | — | — | — | — | — | 0.7 | Khandani et al. (2013) |
37 | Bu2Sn(mstsc) | — | — | — | — | — | — | — | 0.1 | Khandani et al. (2013) |